170 related articles for article (PubMed ID: 3022897)
21. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma.
Banatvala JE; Best JM; Waller DK
Lancet; 1972 Jun; 1(7762):1205-8. PubMed ID: 4113190
[No Abstract] [Full Text] [Related]
22. The kissing virus.
Haire M
Ulster Med J; 1981; 50(1):1-9. PubMed ID: 6262973
[No Abstract] [Full Text] [Related]
23. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
Henle W; Henle G
Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
[No Abstract] [Full Text] [Related]
24. [Immunological study of nasopharyngeal carcinoma].
Tachibana T
Nihon Ishikai Zasshi; 1971 Jun; 65(11):1387-98. PubMed ID: 4327018
[No Abstract] [Full Text] [Related]
25. Epstein-Barr virus (EBV). IV. Studies on experimental inactivated vaccine against human EBV infection.
Pătraşcu IV; Tache M
Virologie; 1988; 39(1):29-33. PubMed ID: 2837001
[TBL] [Abstract][Full Text] [Related]
26. [Seroepidemiology of Epstein-Barr virus].
Pannuti CS
Rev Saude Publica; 1981 Feb; 15(1):93-100. PubMed ID: 6275491
[No Abstract] [Full Text] [Related]
27. The Leeuwenhoek lecture, 1983. A prototype vaccine to prevent Epstein-Barr virus-associated tumours.
Epstein MA
Proc R Soc Lond B Biol Sci; 1984 Mar; 221(1222):1-20. PubMed ID: 6144103
[TBL] [Abstract][Full Text] [Related]
28. [Epstein-Barr virus infections--clinical characteristics and diagnosis].
Ernberg I; Andersson J; Linde A
Lakartidningen; 1989 Oct; 86(43):3656-61. PubMed ID: 2554079
[No Abstract] [Full Text] [Related]
29. Epstein-Barr virus in human disease.
Langenhuysen MM; The TH
Neth J Med; 1973; 16(2):85-93. PubMed ID: 4350284
[No Abstract] [Full Text] [Related]
30. Vaccination against EB virus.
Br Med J; 1976 Dec; 2(6050):1467-8. PubMed ID: 187278
[No Abstract] [Full Text] [Related]
31. [Epstein-Barr virus and neoplasms].
Rupniewska ZM
Acta Haematol Pol; 1979; 10(3):193-204. PubMed ID: 228519
[No Abstract] [Full Text] [Related]
32. Virus-specified proteins and their breakdown products. In: strategy of the viral genome.
Ciba Found Symp; 1971; ():295-315. PubMed ID: 4337205
[No Abstract] [Full Text] [Related]
33. [Immunobiology of cancer].
Oettgen HF
Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1973; 205(1):21-36. PubMed ID: 4349192
[No Abstract] [Full Text] [Related]
34. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
35. Recent studies with EB virus.
Epstein MA
Yale J Biol Med; 1975 Nov; 48(5):431-7. PubMed ID: 174330
[No Abstract] [Full Text] [Related]
36. Cell-mediated immune responses in man to Epstein-Barr (EB) virus infection.
Lai PK; Alpers MP
Comp Immunol Microbiol Infect Dis; 1979; 2(4):565-85. PubMed ID: 232867
[No Abstract] [Full Text] [Related]
37. Host responses to herpesviruses - a review.
Henle W; Henle G
IARC Sci Publ (1971); 1975; (11 Pt 2):215-24. PubMed ID: 191365
[No Abstract] [Full Text] [Related]
38. Clinical syndromes associated with EB virus infection.
Evans AS
Adv Intern Med; 1972; 18():77-93. PubMed ID: 4351197
[No Abstract] [Full Text] [Related]
39. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
Pearson G; Dewey F; Klein G; Henle G; Henle W
J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
[TBL] [Abstract][Full Text] [Related]
40. [Viral infections of the hematopoietic system: Epstein-Barr-virus and other less characterized viral infections].
zur Hausen H
Verh Dtsch Ges Pathol; 1981; 65():146-51. PubMed ID: 6289545
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
